Showing results (821-830 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|February 3, 2023
The signaling function of IDO1 incites the malignant progression of mouse B16 melanomaE Orecchini, M L Belladonna, M T Pallotta, et al.
Oncoimmunology|February 17, 2023
Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer PatientsBelinda Palermo, Marta Bottero, Mariangela Panetta, et al.
Oncoimmunology|February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockadePedro Rocha, Rafael Bach, Laura Masfarré, et al.
Oncoimmunology|February 21, 2025
Patient-specific HLA-I subtypes predict response to immune checkpoint blockadeKyrillus S Shohdy, Jack Atherton, Jessica Longland, et al.
Oncoimmunology|February 13, 2025
The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defenseElena Lo Presti, Francesca Cupaioli, Daniela Scimeca, et al.
Oncoimmunology|February 17, 2025
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responsesRita Turpin, Karita Peltonen, Jenna H Rannikko, et al.
Oncoimmunology|November 26, 2024
Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancerSanghoon Lee, Youngbin Cho, Yiting Li, et al.
Oncoimmunology|November 22, 2024
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomasSantosh Kesari, Alexandre Wojcinski, Sarabjot Pabla, et al.
Oncoimmunology|October 8, 2024
Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapyPeng Liu, Liwei Zhao, Guido Kroemer, et al.
Oncoimmunology|August 23, 2024
FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy populationMichaël Constantinides, Nicolas Robert, Caroline Multrier, et al.
Pageof 379